Transcranial magnetic stimulation in the acute treatment of major depressive disorder: Clinical response in an open-label extension trial.
Acknowledgement to the authors: David H. Avery, M.D.; Keith E. Isenberg, M.D.; Shirlene M. Sampson, M.D.; Philip G. Janicak, M.D.; Sarah H. Lisanby, M.D.; Daniel F. Maixner, M.D.; Colleen Loo, M.D.; Michael E. Thase, M.D.; Mark A. Demitrack, M.D.; and Mark S. George, M.D.
Date: 2008
TMS Acute treatment of Major Depressive Disorder (2008) Journal of Clinical Psychiatry
This report describes the results of an open-label extension study of active transcranial magnetic stimulation (TMS) in medication-resistant patients with major depressive disorder who did not benefit from an initial course of therapy in a previously reported 6-week, randomized controlled study of active versus sham TMS.
Updated: 6 August 2025
